Antares Pharma reported $18.24M in Loan Capital for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Abbott ABT:US $ 17086M 210M
Abbvie ABBV:US $ 63522M 667M
Adma Biologics ADMA:US $ 138.42M 43.56M
Aerie Pharmaceuticals AERI:US $ 311.68M 77.15M
Ani Pharmaceuticals ANIP:US $ 286.31M 213K
Atrion ATRI:US 0 0
Becton, Dickinson and BDX:US $ 17584M 1224M
Cara Therapeutics CARA:US $ 0 0
Cerus CERS:US $ 54.77M 45K
Eli Lilly And LLY:US $ 15152.9M 193.5M
Endo International Ordinary Shares ENDP:US $ 8057.5M 9.85M
Horizon Pharma HZNP:US $ 2552.74M 2.49M
JAZZ PHA JAZZ:US $ 5992.87M 32.34M
Meridian Bioscience VIVO:US $ 25M 25M
Orasure Technologies OSUR:US $ 1.21M 0.74M
Pacira Pharmaceuticals PCRX:US $ 729.74M 55.21M
Pfizer PFE:US $ 35656M 539M
Revance Therapeutics RVNC:US $ 430.86M 150.23M
Sientra SIEN:US $ 65.58M 3.12M
Staar Surgical STAA:US $ 0.34M 0.04M
Supernus Pharmaceuticals SUPN:US $ 400.38M 21.13M
Teva Pharmaceutical TEVA:IT 20.84B 777M
Teva Pharmaceutical Industries TEVA:US $ 20840M 777M
Utah Medical Products UTMD:US 0 0